Magn Reson Med 2002 Jun;47(6):1100-9
Barbier EL, Lawrence KS, Grillon E, Koretsky AP, Decorps M.
INSERM U438, RMN Bioclinique, Grenoble, France.
A noninvasive technique for measuring the permeability of the blood-brain barrier (BBB) to water could help to evaluate changes in the functional integrity of the BBB that occur in different pathologies, such as multiple sclerosis or growth of brain tumor.
Recently, Schwarzbauer et al. (Magn Reson Med 1997;37:769-777) proposed an MR method to measure this permeability based on the T(1) reductions induced by injecting various doses of paramagnetic contrast agent.
However, this method may be difficult to implement in a clinical environment.
Described here is a two-point technique, in which a spatially selective inversion is used to measure T(1) prior to and after injection of an intravascular contrast agent.
Measurements made in the rat brain are compared to numerical simulations generated with a physiological model that accounts for blood flow and includes two different blood volumes: nonexchanging and exchanging blood volumes.
Our results suggest that BBB permeability could be evaluated from the change in T(1) caused by the vascular contrast agent.
This technique might provide an approach for monitoring changes in BBB permeability to water in clinical studies.
Copyright 2002 Wiley-Liss, Inc